levofloxacin has been researched along with retinol in 4 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (retinol) | Trials (retinol) | Recent Studies (post-2010) (retinol) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 25,529 | 1,564 | 4,425 |
| Protein | Taxonomy | levofloxacin (IC50) | retinol (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.18 | |
| Alpha-synuclein | Homo sapiens (human) | 0.19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aksoy, F; Altuntas, E; Dogan, R; Guler, B; Ozturan, O; Topcu, G; Yener, FG | 1 |
1 review(s) available for levofloxacin and retinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for levofloxacin and retinol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effect of a combination of mometasone furoate, levofloxacin, and retinyl palmitate with an in situ gel-forming nasal delivery system on nasal mucosa damage repair in an experimental rabbit model.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Proliferation; Diterpenes; Drug Delivery Systems; Drug Therapy, Combination; Gels; Levofloxacin; Male; Models, Animal; Mometasone Furoate; Nasal Mucosa; Rabbits; Random Allocation; Retinyl Esters; Treatment Outcome; Vitamin A; Wound Healing | 2017 |